Comment on "Resection of the Primary Gastrointestinal Neuroendocrine Tumor Improves Survival With or Without Liver Treatment"

Ann Surg. 2021 Dec 1;274(6):e758-e759. doi: 10.1097/SLA.0000000000004262.

Authors

Qi-Chen Chen, Qi-Wen Zheng¹, Sheng Luo², Hong Zhao³

Affiliations

¹ Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.
² Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.
³ Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

PMID: 33065634
DOI: 10.1097/SLA.0000000000004262

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Intestinal Neoplasms*
Liver
Neuroendocrine Tumors* / surgery
Pancreatic Neoplasms*
Stomach Neoplasms*